Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,250,200 | 4,108,000 | 1,573,800 | 1,548,100 | 1,169,500 |
| Marketable Securities | 1,974,000 | 1,808,000 | 2,115,200 | 1,960,200 | 1,723,500 |
| Receivables | 1,951,000 | 1,939,200 | 1,787,000 | 1,567,500 | 1,630,200 |
| Inventories | 931,700 | 906,600 | 902,700 | 1,007,200 | 936,500 |
| Other current assets | 1,325,200 | 1,433,600 | 1,494,600 | 1,485,000 | 1,649,000 |
| TOTAL | $7,432,100 | $10,195,400 | $7,873,300 | $7,568,000 | $7,108,700 |
| Non-Current Assets | |||||
| PPE Net | 3,409,000 | 3,334,700 | 3,182,400 | 2,995,900 | 2,827,600 |
| Investments And Advances | 2,062,300 | 1,580,300 | 3,488,900 | 4,362,400 | 3,901,000 |
| Intangibles | 8,831,600 | 8,702,300 | 8,512,100 | 8,146,900 | 7,921,700 |
| Other Non-Current Assets | 2,217,900 | 2,277,400 | 595,900 | 0 | 0 |
| TOTAL | $16,520,800 | $15,894,700 | $15,779,300 | $15,505,200 | $14,650,300 |
| Total Assets | $23,952,900 | $26,090,100 | $23,652,600 | $23,073,200 | $21,759,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 295,700 | 345,800 | 395,500 | 298,700 | 330,300 |
| Accrued Expenses | 2,633,700 | 2,571,100 | 2,901,300 | 2,455,200 | 2,436,900 |
| TOTAL | $3,152,400 | $3,152,100 | $3,368,200 | $3,448,400 | $3,379,700 |
| Non-Current Liabilities | |||||
| Long Term Debt | 5,928,400 | 5,929,400 | 5,935,000 | 5,938,300 | 5,954,000 |
| aiOther Non-Current Liabilities | 1,409,200 | 1,641,700 | 1,497,600 | 716,900 | 750,900 |
| TOTAL | $8,546,800 | $8,900,500 | $7,686,300 | $6,775,900 | $6,805,700 |
| Total Liabilities | $11,699,200 | $12,052,600 | $11,054,500 | $10,224,300 | $10,185,400 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 201,443 | 211,008 | 211,563 | 211,477 | 211,432 |
| Common Shares | 100 | 100 | 100 | 100 | 100 |
| Retained earnings | 15,499,500 | 17,334,600 | 15,810,400 | 16,107,700 | 14,881,700 |
| Other shareholders' equity | -268,900 | -320,200 | -333,200 | -341,100 | -350,500 |
| TOTAL | $12,253,700 | $14,037,500 | $12,598,100 | $12,848,900 | $11,573,600 |
| Total Liabilities And Equity | $23,952,900 | $26,090,100 | $23,652,600 | $23,073,200 | $21,759,000 |